Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04060342
Title GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
UCSF Medical Center at Mission Bay San Francisco California 94158 United States Details
University of Colorado Hospital, Anschutz Cancer Pavilion (ACP) Aurora Colorado 80045 United States Details
Washington University School of Medicine - Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
The Sarah Cannon Research Institute/Tennessee Oncology Nashville Tennessee 37203 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
The Royals Marsden NHS Foundation Trust Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field